<?xml version="1.0" encoding="UTF-8"?>
<p id="Par46">In search of suitable vaccine against SARS-CoV-2, mRNA-based vaccine (mRNA-1273) by Moderna (NASDAQ: MRNA), INO-4800 by Inovio pharmaceuticals (NASDAQ-INO) and vaccines by other company such as CanSino Biologics, Sinovac Biotech Ltd., Johnson &amp; Johnson, among others, are being developed and they have reached final stages of clinical trials [
 <xref ref-type="bibr" rid="CR47">47</xref>, 
 <xref ref-type="bibr" rid="CR205">205</xref>]. Moreover, a joint effort is made by Oxford University and Rocky Mountain Laboratories to develop a chimpanzee adenovirus vectored vaccine (ChadOx1)[
 <xref ref-type="bibr" rid="CR206">206</xref>].
</p>
